Skip to Content

Z 22 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint Z 22 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Aurobindo Pharma Limited.

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Z 22

Darifenacin Hydrobromide Extended-Release

Imprint
Z 22
Strength
7.5 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
National Drug Code (NDC)
65862-0861
Inactive Ingredients
silicon dioxide, calcium phosphate dihydrate dibasic, ethylcellulose (10 mPa.s), hydroxyethyl cellulose (4000 mpa.s at 1%), hydroxypropyl cellulose, hypromellose 2910 (5 mPa.s), lactose monohydrate, magnesium stearate, polyethylene glycol 6000, povidone k30, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "Z 22"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.